Can we improve ABVD in Hodgkin's lymphoma?
Hopital Saint Louis, 1 Avenue Claude Vellefaux, Paris 7510, France. Electronic address: Christian.gisselbrecht@sls.aphp.fr.
Christian
C
Gisselbrecht
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D000079963:Brentuximab Vedotin; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D018796:Immunoconjugates / Q000008:administration & dosage*; D008297:Male
D018796:Immunoconjugates; D000079963:Brentuximab Vedotin